Home Filling in the GAPS: validation of anion gap (AGAP) measurement uncertainty estimates for use in clinical decision making
Article
Licensed
Unlicensed Requires Authentication

Filling in the GAPS: validation of anion gap (AGAP) measurement uncertainty estimates for use in clinical decision making

  • Jessica L. Gifford and Isolde Seiden-Long ORCID logo EMAIL logo
Published/Copyright: April 20, 2022

Abstract

Objectives

We compare measurement uncertainty (MU) calculations to real patient result variation observed by physicians using as our model anion gap (AGAP) sequentially measured on two different instrument types. An approach for discretely quantifying the pre-analytical contributions and validating AGAP MU estimates for interpretation of patient results is proposed.

Methods

AGAP was calculated from sodium, chloride, and bicarbonate reported from chemistry or blood gas analyzers which employ different methodologies and specimen types. AGAP MU was calculated using a top-down approach both assuming no correlation between measurands and alternatively, including consideration of measurand correlation. MU-derived reference change values (RCV) were calculated between chemistry and blood gas analyzers results. Observational paired AGAP data (n=39,626 subjects) was obtained from retrospectively analyzed specimens from five urban tertiary care hospitals in Calgary, Alberta, Canada.

Results

The MU derived AGAP RCV for paired specimen data by the two platforms was 5.2–6.1 mmol/L assuming no correlation and 2.6–3.1 mmol/L assuming correlation. From the paired chemistry and blood gas data, total observed variation on a reported AGAP has a 95% confidence interval of ±6.0 mmol/L. When the MU-derived RCV assuming correlation is directly compared against the observed distribution of patient results, we obtained a pre-analytical variation contribution of 2.9–3.5 mmol/L to the AGAP observed variation. In contrast, assuming no correlation leads to a negligible pre-analytical contribution (<1.0 mmol/L).

Conclusions

MU estimates assuming no correlation are more representative of the total variation seen in real patient data. We present a pragmatic approach for validating an MU calculation to inform clinical decisions and determine the pre-analytical contribution to MU in this system.


Corresponding author: Isolde Seiden-Long, Clinical Associate Professor, Alberta Precision Laboratories and Department of Pathology and Laboratory Medicine, University of Calgary, Foothills Medical Centre, McCaig Tower, Rm 7507, 7th Floor, 3134 Hospital Drive NW, Calgary, Canada, E-mail:

  1. Research funding: None declared.

  2. Author contributions: All authors have accepted responsibility for the entire content of this manuscript and approved its submission.

  3. Competing interests: Authors state no conflict of interest.

  4. Informed consent: Not applicable.

  5. Ethical approval: The local Institutional Review Board deemed the study exempt from review.

References

1. ISO/TS 20914:2019. Medical laboratories—practical guidance for the estimation of measurement uncertainty. International Organization for Standardization [Online]; 2019. Available from: https://www.iso.org/standard/69445.html.Search in Google Scholar

2. ISO. ISO 15189:2012. Medical laboratories—requirements for quality and competence. Int Organ Stand [Internet]; 2012. Available from: https://www.iso.org/standard/56115.html.Search in Google Scholar

3. Milinković, N, Jovičić, S, Ignjatović, S. Measurement uncertainty as a universal concept: can it be universally applicable in routine laboratory practice? Crit Rev Clin Lab Sci 2021;58:101–12. https://doi.org/10.1080/10408363.2020.1784838.Search in Google Scholar PubMed

4. Rigo-Bonnin, R, Canalias, F. Measurement uncertainty estimation for derived biological quantities. Clin Chem Lab Med 2020;59:E1–7. https://doi.org/10.1515/cclm-2020-1003.Search in Google Scholar PubMed

5. Farrance, I, Frenkel, R. Measurement uncertainty and the importance of correlation. Clin Chem Lab Med 2020;59:7–9. https://doi.org/10.1515/cclm-2020-1205.Search in Google Scholar PubMed

6. Goguen, J, Gilbert, J. Hyperglycemic emergencies in adults. Can J Diabetes 2018;42:S109–14. https://doi.org/10.1016/j.jcjd.2017.10.013.Search in Google Scholar PubMed

7. Braga, F, Panteghini, M. The utility of measurement uncertainty in medical laboratories. Clin Chem Lab Med 2020;58:1407–13. https://doi.org/10.1515/cclm-2019-1336.Search in Google Scholar PubMed

8. Padoan, A, Sciacovelli, L, Zhou, R, Plebani, M. Extra-analytical sources of uncertainty: which ones really matter? Clin Chem Lab Med 2019;57:1488–93. https://doi.org/10.1515/cclm-2019-0197.Search in Google Scholar PubMed

9. SLRE and AW, editors. Eurachem/CITAC guide: quantifying uncertainty in analytical measurement [Internet], 3rd ed.; 2012. Available from: http://www.eurachem.org.Search in Google Scholar

10. Fraser, CG. Reference change values. Clin Chem Lab Med 2012;50:807–12. https://doi.org/10.1515/cclm.2011.733.Search in Google Scholar PubMed

11. Fraser, CG. Biological variation: a rapidly evolving aspect of laboratory medicine. J Lab Precis Med 2017;2:35. https://doi.org/10.21037/jlpm.2017.06.09.Search in Google Scholar

12. CLSI. CLSI EP29-A. Expression of measurement uncertainty in laboratory medicine. Wayne, PA: CLSI; 2012.Search in Google Scholar

13. Dimeski, G, Morgan, TJ, Presneill, JJ, Venkatesh, B. Disagreement between ion selective electrode direct and indirect sodium measurements: estimation of the problem in a tertiary referral hospital. J Crit Care 2012;27:326.e9–16. https://doi.org/10.1016/j.jcrc.2011.11.003.Search in Google Scholar PubMed

14. Frezzotti, A, Maria, A, Gambini, M, Coppa, G, De Sio, G. Total carbon dioxide measured by the Vitros enzymatic method. Clin Chem Lab Med 1998;36:43–6. https://doi.org/10.1515/cclm.1998.008.Search in Google Scholar PubMed


Supplementary Material

The online version of this article offers supplementary material (https://doi.org/10.1515/cclm-2021-1279).


Received: 2021-12-07
Accepted: 2022-03-14
Published Online: 2022-04-20
Published in Print: 2022-05-25

© 2022 Walter de Gruyter GmbH, Berlin/Boston

Articles in the same Issue

  1. Frontmatter
  2. Reviews
  3. Statistics in diagnostic medicine
  4. Interferences in immunoassays: review and practical algorithm
  5. EFLM Paper
  6. The value proposition of integrative diagnostics for (early) detection of cancer. On behalf of the EFLM interdisciplinary Task and Finish Group “CNAPS/CTC for early detection of cancer”
  7. General Clinical Chemistry and Laboratory Medicine
  8. Benchmarking medical laboratory performance: survey validation and results for Europe, Middle East, and Africa
  9. Pre-analytical stability of serum biomarkers for neurological disease: neurofilament-light, glial fibrillary acidic protein and contactin-1
  10. Filling in the GAPS: validation of anion gap (AGAP) measurement uncertainty estimates for use in clinical decision making
  11. Implementation and challenges of portable blood gas measurements in air medical transport
  12. Calculation of the estimated glomerular filtration rate using the 2021 CKD-EPI creatinine equation and whole blood creatinine values measured with Radiometer ABL 827 FLEX
  13. Dubiously increased FT4 and FT3 levels in clinically euthyroid patients: clinical finding or analytical pitfall?
  14. Two co-inherited hemoglobin variants revealed by capillary electrophoresis during quantification of glycated hemoglobin
  15. Determination of individual bile acids in acute respiratory distress syndrome reveals a specific pattern of primary and secondary bile acids and a shift to the acidic pathway as an adaptive response to the critical condition
  16. Evaluation of a faecal calprotectin method using the OC-SENSOR PLEDIA
  17. Reference Values and Biological Variations
  18. Reference intervals for Sysmex XN hematological parameters as assessed in the Dutch Lifelines cohort
  19. Cardiovascular Diseases
  20. High incidence of discrepancies in new Siemens assay – a comparison of cardiac troponin I assays
  21. Infectious Diseases
  22. Effect of BNT162b2 booster dose on anti-SARS-CoV-2 spike trimeric IgG antibodies in seronegative individuals
  23. The role of neutralizing antibodies by sVNT after two doses of BNT162b2 mRNA vaccine in a cohort of Italian healthcare workers
  24. Continuous monitoring of SARS-CoV-2 seroprevalence in children using residual blood samples from routine clinical chemistry
  25. Prognostic significance of soluble CD25 in patients with sepsis: a prospective observational study
  26. Letters to the Editors
  27. Diagnostic accuracy of the ultrasensitive S-PLEX SARS-CoV-2 N electrochemiluminescence immunoassay
  28. Life-threatening autoimmune hemolytic anemia following mRNA COVID-19 vaccination: don’t be too prudent with the red gold
  29. CSF-interleukin 6 for early diagnosis of ventriculitis in a broad intensive care setting
  30. Clearance of macro-TSH from the circulation is slower than TSH
  31. Biological variation and reference change value as decision criteria in clinical use of tumor biomarkers. Are they really useful?
  32. Testing for anti-Müllerian hormone: analytical performances and usability of a point-of-care assay
  33. Diagnostic performance characteristics of the Quanta Flash Rheumatoid Factor assay in a consecutive Dutch patient cohort
  34. Trimester-specific reference values for the anticardiolipin antibody by chemiluminescence immunoassay in healthy pregnancy
  35. Congress Abstracts
  36. 4th National Point of Care Testing Symposium
Downloaded on 13.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/cclm-2021-1279/html
Scroll to top button